Dose of meropenam and vancomycin
Reading Document
Medical Text Search
meropenem dosing regimens adults renal adjustment
Medical Text Search
vancomycin dosing regimens adults renal adjustment
GradeResponse
GradeResponse
The retrieved results are limited in scope. I'll supplement with comprehensive clinical knowledge to provide a thorough answer.
Meropenem — Dosing
Standard Adult Doses
| Indication | Dose | Interval | Infusion |
|---|---|---|---|
| Mild–moderate infections | 500 mg | q8h | 30 min IV |
| Moderate–severe infections | 1 g | q8h | 30 min IV |
| Severe/life-threatening (e.g., meningitis, febrile neutropenia, nosocomial pneumonia) | 2 g | q8h | 30 min–3h IV |
| Augmented renal clearance (CrCl >130 mL/min) | 1–2 g | q6–8h | Extended/CI |
Renal Dose Adjustment (Adults)
| CrCl (mL/min) | Dose | Interval |
|---|---|---|
| >50 | Standard dose | q8h |
| 26–50 | Standard dose | q12h |
| 10–25 | Half dose | q12h |
| <10 / HD | Half dose | q24h (give after HD) |
Extended infusion (3-hour infusion) is preferred for organisms with higher MICs (e.g., P. aeruginosa, Acinetobacter) to maximize time-dependent killing (fT>MIC).
Vancomycin — Dosing
Standard Adult Doses
| Indication | Dose | Interval |
|---|---|---|
| General serious infections (MRSA, endocarditis, meningitis) | 15–20 mg/kg (actual body weight) | q8–12h IV |
| Loading dose (severe/critically ill) | 25–30 mg/kg (single dose) | Once |
| Max single dose | 3,000 mg | — |
| Max infusion rate | 10–15 mg/min (to avoid Red Man Syndrome) | — |
Typical starting dose in a 70 kg patient: 1,250–1,500 mg q12h
Renal Dose Adjustment
| CrCl (mL/min) | Interval |
|---|---|
| >90 | q8–12h |
| 50–90 | q12h |
| 20–49 | q24h |
| 10–19 | q48–72h |
| <10 / HD | Dose by levels; give after HD |
| CRRT | 1 g q24h (adjust by levels) |
Therapeutic Drug Monitoring (TDM)
The 2020 ASHP/IDSA/SIDP Vancomycin Guidelines recommend AUC-guided dosing over trough-only monitoring:
| Parameter | Target |
|---|---|
| AUC₀₋₂₄ | 400–600 mg·h/L (for serious MRSA infections) |
| Trough (if AUC not available) | 15–20 mg/L |
| Peak (1h post-infusion) | 25–40 mg/L |
Trough-only monitoring is associated with nephrotoxicity; AUC/MIC-guided dosing is now the standard of care.
Key Points
- Meropenem is time-dependent; extended or continuous infusion improves PK/PD outcomes for resistant organisms.
- Vancomycin requires individualized dosing based on weight, renal function, and TDM; always dose per pharmacy protocol.
- Both drugs need renal dose adjustment — meropenem by reducing frequency, vancomycin by extending interval and monitoring levels.
- In hemodialysis: meropenem supplemental dose after each session; vancomycin redosed when trough <10–15 mg/L.
This is a shared conversation. Sign in to Orris to start your own chat.